Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.45 EUR | -1.24% | 0.00% | +10.24% |
07-03 | BRITISH AMERICAN TOBACCO : RBC reiterates its Neutral rating | ZD |
07-02 | BRITISH AMERICAN TOBACCO : UBS remains Neutral | ZD |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- One of the major weak points of the company is its financial situation.
- The company's enterprise value to sales, at 3.28 times its current sales, is high.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.24% | 69.4B | - | ||
+7.80% | 158B | B- | ||
+14.20% | 22.13B | A- | ||
+33.54% | 6.73B | B- | ||
+108.68% | 2.67B | - | C+ | |
-1.41% | 1.82B | - | ||
-2.84% | 1.73B | - | D+ | |
-29.41% | 1.17B | - | B+ | |
0.00% | 643M | - | - | |
+25.38% | 582M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BATS Stock
- BMT Stock
- Ratings British American Tobacco p.l.c.